Catalyst Wire Dossier Catalyst Wire Dossier

Tagraxofusp

tagraxofusp · Stemline Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Tagraxofusp, covering 2024-08-01 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes [Phase 1, Phase 2]

See pricing